We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Boehringer Ingelheim Licenses MetaCore From GeneGo

Read time: Less than a minute

GeneGo, Inc. has announced that Boehringer Ingelheim has licensed its data mining suite, MetaCore, primarily for toxicogenomics research.

MetaCore is based on a comprehensive, manually curated database of human biology, diseases, toxicology and bioactive chemistry.

"Toxicogenomics is one of the main applications of MetaCore, and we pay a lot of attention to the field in product development," said Julie Bryant, Vice President of Business Development at GeneGo.

"We manually curate all major toxicity journals and develop tools and workflows specifically for the analysis of toxicogenomics datasets; the work is partly sponsored by an NIEHS grant."

"MetaCore was featured in many posters and presentations at the recent Society of Toxicology meeting in San Diego, and is applied by a growing number of toxicogenomics groups in industry and academia."

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.